{"title":"反应性感染性皮肤粘膜爆疹的诊断与治疗。","authors":"Nicole Damari, Abbie Goodman, Catherine Bridges","doi":"10.1002/jhm.70099","DOIUrl":null,"url":null,"abstract":"<p><p>Medicine's clinical understanding of reactive infectious mucocutaneous eruption (RIME) has evolved over time. It was previously described as Mycoplasma pneumoniae-induced rash and mucositis (MIRM), and before that as a variant of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Here, we summarize the current understanding of best practices for RIME diagnosis and management.</p>","PeriodicalId":94084,"journal":{"name":"Journal of hospital medicine","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2025-07-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Diagnosis and management of reactive infectious mucocutaneous eruption.\",\"authors\":\"Nicole Damari, Abbie Goodman, Catherine Bridges\",\"doi\":\"10.1002/jhm.70099\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Medicine's clinical understanding of reactive infectious mucocutaneous eruption (RIME) has evolved over time. It was previously described as Mycoplasma pneumoniae-induced rash and mucositis (MIRM), and before that as a variant of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Here, we summarize the current understanding of best practices for RIME diagnosis and management.</p>\",\"PeriodicalId\":94084,\"journal\":{\"name\":\"Journal of hospital medicine\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2025-07-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of hospital medicine\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1002/jhm.70099\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of hospital medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/jhm.70099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Diagnosis and management of reactive infectious mucocutaneous eruption.
Medicine's clinical understanding of reactive infectious mucocutaneous eruption (RIME) has evolved over time. It was previously described as Mycoplasma pneumoniae-induced rash and mucositis (MIRM), and before that as a variant of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis. Here, we summarize the current understanding of best practices for RIME diagnosis and management.